With a rich legacy of experience and expertise, C&R Research has partnered with Koreaâ€™s health and medical industries in clinical development for the past 20 years, since its foundation in 1997. To date, C&R Research has carried out a total of 1,200 clinical trials, coupled with drug license services, thus emerging as Asiaâ€™s representative contract research organizations (CRO) beyond Korea. In an age of the fourth Industrial Revolution, Koreaâ€™s pharmaceutical and medical device industries are likely to face more intensified global competition landscape. To become a forerunner to lead the new industrial paradigm, seeking business diversification and globalization on the part of Korean companies will be an integral part for success. C&R Researchâ€™s expertise is backed with over 20 yearsâ€™ experience and global networks. We will spare no effort to provide services customized to the needs of Korean companies in all phases of clinical trials (i.e., from discovery of new chemical entities to commercialization) by improving our global clinical capabilities and reinforcing the platform functions to suggest guidance on the way to rapid and successful advancement of our clients into global arena. It is our ultimate mission to contribute to new drug development and human healthcare as a leading CRO in the long run. Without dwelling on its past brilliant growth, C&R Research is poised for taking off another 20 years of growth and to this end, the company will further strengthen its proactive services and faithfully undertake its assigned role as the best reliable partner to be recognized in the global healthcare industry. We look forward to your continuous patronage and supporting the years to come.
Offices in :
Daechi MS Bldg., 412 Yeoksam-ro, Gangnam-gu, Seoul